Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Offices

San Diego, USA
11180 Roselle Street
San Diego, CA, 92121
USA

Funding

Tags

Effector Therapeutics

eFFECTOR Therapeutics is an early stage company focused on the discovery and development of new small molecule cancer therapeutics. eFFECTOR is developing translation regulators to selectively block disregulated translation impacting tumor growth and survival. The company has selected control of mRNA translation as a key point of theerapeutic intervention, providing potency and selectivity while inhibiting growth of cancer cells. eFFECTOR’s novel approach provides a real opportunity to bring innovative new medicines to patients in need.

Recent Milestones

Videos

Screenshots

Effector Therapeutics screenshot
Above: Homepage
Uploaded: 5/17/13

Sources

  1. Effector Therapeutics snags $45M venture round from A-list backers (fiercebiotech.com) [edit]
Edit This Page
Last Edited 3/14/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy